Key facts
- Pictor Labs’s last known valuation is $84.6M (Jan 2025).
- It has raised $39.4M across 3 recorded rounds; the latest was Early Stage VC ($20.6M) in Aug 2024.
- Notable investors include Insight Partners (New York), Western Technology Investment, University of California, MicroVentures, M Ventures — 10 tracked in total.
- Pictor Labs has filed 5 Form Ds with the SEC since 2020, most recently Aug 2024 ($20.6M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Pictor Labs
Funding rounds
3 roundsAbout Pictor Labs
Developer of a digital imaging platform designed to conduct histopathology. The company's platform uses an accurate generative adversarial network, related methods, and proprietary algorithms to ingest a high-resolution image of an unprocessed and unstained tissue sample, enabling clinicians to effectively carry out tissue diagnoses.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2019
- Employees
- 35
- Website
- pictorlabs.ai/
- Ownership
- Privately Held (backing)
Pictor Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pictor Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pictor Labs in its N-PORT filings yet. We sweep new filings monthly.